Copeptin as a Biomarker for Central Diabetes Insipidus Development Following Pituitary Surgery
Conditions:   Sellar and Suprasellar Masses;   Pituitary Tumor Intervention:   Sponsor:   Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2020 Category: Research Source Type: clinical trials

Use of Copeptin Measurement After Arginine Infusion for the Differential Diagnosis of Diabetes Insipidus - the CARGOx Study
Conditions:   Diabetes Insipidus;   Polydipsia, Primary Interventions:   Diagnostic Test: Arginine infusion;   Diagnostic Test: Hypertonic saline infusion Sponsors:   University Hospital, Basel, Switzerland;   Kantonsspital Aarau;   Luzerner Kantonsspital;   Kantonsspital St. Gallen, Switzerland;   University Hospital, Zürich;   Wuerzburg University Hospital;   University Hospital Lübeck;   Federal University of Minas Gerais Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2018 Category: Research Source Type: clinical trials